Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Thermo Fisher Scientific Expands Access to Peanut Allergy Tests

Published: Wednesday, August 21, 2013
Last Updated: Wednesday, August 21, 2013
Bookmark and Share
The Thermo Scientific ImmunoCAP peanut component tests are now available through the co-marketing and distribution collaboration with Quest Diagnostics.

Quest Diagnostics is the first national diagnostic information services provider to broadly offer diagnostic services based on the ImmunoCAP tests to physicians, significantly broadening patient access. Under a non-exclusive agreement, the two companies will also co-market ImmunoCAP test services provided by Quest Diagnostics’ clinical laboratories. Additional terms were not disclosed.

“Quest Diagnostics has long-standing expertise with ImmunoCAP technologies. The addition of the ImmunoCAP Peanut Component Tests to Quest’s ImmunoCAP menu extends physician and patient access to these important diagnostic tools,” said Joseph Bernardo, president, immunodiagnostics, for Thermo Fisher Scientific. “The more that patients, in consultation with their doctors, know about their specific exposure risks to peanut allergens, the safer they and their families may be from this potential health risk.”

Unlike skin scratch testing, the ImmunoCAP Peanut Component tests measure a patient’s Immunoglobulin E, or IgE, sensitization to five important individual peanut proteins, called allergen components. Some of these components are known to be responsible for severe allergic reactions in sensitized patients. Physicians may use this information to identify patients who have a good chance of passing an oral food challenge and to develop personalized treatment plans tailored to a patient’s individual risk.

Peanuts and tree nuts are the most common cause of fatal and near-fatal allergic reactions to food in the United States. A Quest Diagnostics Health Trends study published in 2011 found that peanuts were the most common source of food allergen sensitization in children ages six to 18 years of age, affecting nearly one in four tested by the company.

While some peanut sensitized patients may react to components in the peanut that can cause severe and potentially life-threatening reactions, other patients may react only to components that usually cause only mild localized reactions. Results from peanut component testing can help to stratify a patient’s risk and identify those patients likely to pass an oral food challenge.

“Many parents fear that their children may be at risk of a severe allergic reaction to peanuts, and these children often live restricted lives as a result,” said Stanley J. Naides, M.D., medical director, Immunology R&D, Quest Diagnostics. “ImmunoCAP component technology takes peanut allergy testing to the next level, providing not only the ability to identify allergen sensitization but may also help physicians predict the likelihood of a systemic reaction upon allergen exposure. That’s the kind of critical diagnostic insight that can empower patients and create a healthier world.”

Other ImmunoCAP blood allergy tests available to physicians through Quest Diagnostics include component testing for milk, egg and respiratory allergens.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Completes $4.2B FEI Acquisition
Business will become part of Thermo Fisher’s Analytical Instruments Segment.
Thursday, September 22, 2016
Thermo Fisher Opens New Clinical Services Facility in Korea
The new site will provide local, regional and global pharmaceutical and biotech companies with a one-stop service for clinical supplies.
Thursday, September 15, 2016
Thermo Fisher, HBM Collaborate
Collaboration aims to support molecular diagnostics development in China.
Friday, July 29, 2016
Thermo, DuPont Extend Food Safety Agreement
Thermo Fisher scientific and DuPont Nutrition & Health extend BAX System Q7 Distribution agreement in Western Europe for an additional three years.
Thursday, July 14, 2016
Thermo Fisher, Cytonome/ST Announce Partnership
Partnership aims to focus on the development of a new line of flow cytometry cell sorting platforms.
Tuesday, June 28, 2016
Thermo Recognizes Tandem Mass Tag Grant Award Winners at ASMS 2016
International competition rewards three top proteomics researchers for outstanding innovation and impact.
Thursday, June 09, 2016
Native Mobile Capabilities Added to Thermo SampleManager
One of world’s most widely deployed LIMS continues to add functionality that modern labs require.
Monday, March 14, 2016
Thermo, Children’s Hospital Los Angeles Partner
Children’s Hospital Los Angeles (CHLA) and Thermo Fisher Scientific have agreed to develop a next-generation sequencing (NGS)-based panel designed specifically for pediatric cancer research. The assay would be CHLA’s first NGS panel designed to target biomarkers associated with childhood cancers.
Friday, February 19, 2016
Thermo Scientific Gemini Handheld Chemical Analyzer Wins R&D 100 Award
Two-in-one portable device also earns Editor’s Choice in Analytical/Test category for 2015 by R&D Magazine.
Thursday, November 26, 2015
Thermo Scientific Signs Agreement with Novartis, Pfizer
Universal test designed for non-small cell lung cancer supports multiple drug development programs.
Thursday, November 26, 2015
Thermo Scientific Opens New GMP Clinical Services Facility in Singapore
New regional BioPharma Services hub offers larger operational space and advanced equipment to meet increasing clinical supply needs for pharma and biotech customers.
Saturday, November 21, 2015
Thermo Scientific Manufacturing Site to Meet Guidelines for 18385 Certification
A new standard proposed by the International Organization for Standardization.
Thursday, October 15, 2015
Thermo Fisher Scientific Announces Winners of 2016 Winter Conference Awards in Plasma Spectrochemistry
Independent committee recognizes significant contributions in plasma spectrochemistry.
Wednesday, September 23, 2015
Thermo Fisher Scientific Receives IVDD CE Mark for LC-MS Products
Now available to clinical laboratories in Europe for general in vitro diagnostic use.
Friday, September 11, 2015
Thermo Launches Geneticon
Thermo Fisher Scientific launches GenetiCon, a virtual resource showcasing the real-life science behind superheroic powers and more.
Tuesday, July 07, 2015
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Agilent Presents Early Career Professor Award to Dr. Roeland Verhaak
JAX professor recognized for the development and implementation of workflows for the analysis of big-data from transcriptomics to next generation sequencing approaches.
NIH Study Determines Key Differences between Allergic and Non-Allergic Dust Mite Proteins
Researchers at NIH have uncovered factors that lead to the development of dust mite allergy and assist in the design of better allergy therapies.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos